Newsroom

Recent News Releases

November 15, 2018 11/15/2018 Takeda Announces Issuance of Unsecured U.S. Dollar Denominated Senior Notes

November 15, 2018 11/15/2018 Takeda Announces Pricing of its Unsecured Euro Denominated Senior Notes

November 12, 2018 11/12/2018 Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in relation to the Proposed Acquisition of Shire

November 8, 2018 11/8/2018 Takeda Announces Issuance of Unsecured Euro Denominated Senior Notes

November 7, 2018 11/7/2018 Takeda Announces Launch of Entyvio^® (vedolizumab) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis in Japan

SEE ALL NEWS AND RELEASES >

Featured Topics

Research study highlights that it really does help to walk in a patient’s shoes

LEARN MORE

R&D events at Takeda highlight our transformation into a leading, global pharmaceutical company

LEARN MORE

Shonan Health Innovation Park Grand Opening

LEARN MORE

Takeda’s CSR in Action: Helping Save Children's Lives Through Immunization

LEARN MORE

2017 Winners and Finalists Honored at Awards Ceremony at NYAS in New York City

LEARN MORE

FOR MORE TOPICS>

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.